Showing results (231-240 of 328) with videos related to
Sort By:
Pageof 33
British Journal of Haematology|September 21, 2001
Intravenous busulphan for conditioning before autologous or allogeneic human blood stem cell transplantationU S Schuler, U D Renner, F Kroschinsky, et al.Deutsche Medizinische Wochenschrift (1946)|April 11, 1986
[Bone marrow transplantation in severe aplastic anemia]P Ostendorf, G Ehninger, H Schmidt, et al.Leukemia|January 16, 2004
P-glycoprotein-mediated drug efflux is a resistance mechanism of chronic myelogenous leukemia cells to treatment with imatinib mesylateT Illmer, M Schaich, U Platzbecker, et al.Blood|September 1, 1993
Lymphocytopenia as an unfavorable prognostic factor in patients with cytomegalovirus infection after bone marrow transplantationH Einsele, G Ehninger, M Steidle, et al.Annals of Hematology|November 1, 1995
High-dose cytosine arabinoside and daunorubicin postremission therapy in adults with de novo acute myeloid leukemia. Long-term follow-up of a prospective multicenter trialG Heil, P S Mitrou, D Hoelzer, et al.Bone Marrow Transplantation|October 26, 2005
Graft clonogenicity and intensity of pre-treatment: factors affecting outcome of autologous peripheral hematopoietic cell transplantation in patients with acute myeloid leukemia in first remissionD Strodtbeck, M Bornhäuser, M Hänel, et al.Haematologica|August 16, 2000
Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysisM Bornhäuser, C Theuser, S Soucek, et al.Cancer Genetics and Cytogenetics|June 27, 2001
Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signalsB Mohr, M Bornhäuser, U Platzbecker, et al.European Journal of Cancer & Clinical Oncology|July 1, 1988
Escalating dose regimen of intraperitoneal mitoxantrone: phase I study--clinical and pharmacokinetic evaluationB Blöchl-Daum, H G Eichler, H Rainer, et al.Onkologie|February 1, 1987
Phase-I study of intraperitoneal mitoxantrone--clinical and pharmacokinetic evaluationB Blöchl-Daum, H G Eichler, H Rainer, et al.Pageof 33